Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
Autor: | Queiro, R, Canete, JD, Montilla, C, Abad, MA, Montoro, M, Gomez, S, Cabez, A, Alonso, JCT, Roman-Ivorra, JA, Sanz, J, Salvatierra, J, Calvo-Alen, J, Sellas, A, Rodriguez, FJ, Bermudez, A, Romero, M, Riesco, M, Cobeta, JC, Medina, F, Aragon, A, Garcia, ML, Urruticoechea, A, Gonzalez, CM, Judez, E, Gonzalez, B, Fernandez, P, Pantoja, L, Morla, R |
---|---|
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | JOURNAL OF RHEUMATOLOGY r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname |
ISSN: | 0315-162X |
Popis: | Objective. To examine the grade of agreement between very low disease activity (VLDA) and Disease Activity Index for Psoriatic Arthritis (DAPSA) remission, as well as their association with the effect of the disease as assessed by the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire in patients with psoriatic arthritis in routine clinical practice. Methods. Posthoc analysis of data from a cross-sectional multicenter study. Patients were included who fulfilled the Classification for Psoriatic Arthritis (CASPAR) criteria with at least 1 year of disease duration and were treated with biological and/or conventional synthetic disease-modifying antirheumatic drugs according to routine clinical practice in Spain. Patients were considered in VLDA if they met 7/7 of the minimal disease activity criteria. DAPSA and clinical (c) DAPSA score |
Databáze: | OpenAIRE |
Externí odkaz: |